Your browser doesn't support javascript.
loading
Brother's Keeper: Wild-Type Mutant K-Ras Dimers Limit Oncogenesis.
Lin, Yi-Jang; Haigis, Kevin M.
Afiliación
  • Lin YJ; Cancer Research Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Haigis KM; Cancer Research Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA. Electronic address: khaigis@bidmc.harvard.edu.
Cell ; 172(4): 645-647, 2018 02 08.
Article en En | MEDLINE | ID: mdl-29425486
ABSTRACT
K-Ras is the undisputed champion of oncogenes, yet our ability to interfere with its oncogenic function is hampered by insufficient mechanistic understanding. In this issue of Cell, Ambrogio and colleagues connect the ability of K-Ras to dimerize to the ability of wild-type K-Ras to limit the oncogenic properties of the mutant.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas p21(ras) / Hermanos Límite: Humans / Male Idioma: En Revista: Cell Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas p21(ras) / Hermanos Límite: Humans / Male Idioma: En Revista: Cell Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos